BerGenBio ASA
Latest round
- Series A
Last raised
- Jan 2012
Total raised
- $8.8M
Investors
- 2
About BerGenBio ASA
Founded in 2007 and headquartered in Bergen, Norway, BerGenBio ASA specializes in the development of first-in-class AXL inhibitors. The company's notable global presence includes operations aimed at addressing treatments for cancer and severe respiratory infections. CEO Martin Olin leads the firm, which has executed a total of 7 deals.BerGenBio develops first-in-class AXL inhibitors targeting aggressive diseases, focusing primarily on cancer and severe respiratory infections. Their main product, BEMCENTINIB, inhibits the AXL receptor tyrosine kinase, essential in cancer progression and immune evasion. The company is focused on advancing its flagship product, BEMCENTINIB, and expanding its market reach into new geographic regions, specifically targeting additional markets in Europe and North America by 2024.
Who invested in BerGenBio ASA
2 investors across 1 round
See all investors in BerGenBio ASA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 4, 2012
Amount
$8.8M
Investors
Questions about BerGenBio ASA
Who invested in BerGenBio ASA?
BerGenBio ASA has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BerGenBio ASA raised?
BerGenBio ASA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BerGenBio ASA last raise money?
BerGenBio ASA's most recent round on record is a Series A, in Jan 2012.
What does BerGenBio ASA do?
Founded in 2007 and headquartered in Bergen, Norway, BerGenBio ASA specializes in the development of first-in-class AXL inhibitors.
Where is BerGenBio ASA headquartered?
BerGenBio ASA is headquartered in Bergen, Norway.
Which VCs invest in companies like BerGenBio ASA?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at BerGenBio ASA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BerGenBio ASA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.